Guangdong Silver Jubilee Technology Co., Ltd. 2025 Independent Director Performance Report (Wei Long)
To all shareholders and shareholder representatives:
As an independent director of the sixth board of Guangdong Silver Jubilee Technology Co., Ltd. (hereinafter referred to as the "Company"), I have strictly followed the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Management Measures for Independent Directors of Listed Companies," and the "Articles of Association of Guangdong Silver Jubilee Technology Co., Ltd." (hereinafter referred to as the "Articles of Association"), and the "Work Rules for Independent Directors." In 2025, I have conscientiously, diligently, and faithfully performed my duties, actively attended the relevant meetings in 2025 as required, carefully reviewed all proposals of the board of directors, fully exercised the role of independent director and member of various professional committees, and effectively protected the legitimate rights and interests of the Company and shareholders, especially small and medium shareholders. The following is a report on my performance as an independent director in 2025:
I. Basic Information of Independent Director
Mr. Wei Long: Chinese national, born in 1970, with no permanent overseas residency. He graduated from Zhongnan University of Economics and Law with a Master's degree. Since January 2002, he has been a full-time lawyer at Guangdong Fu Cheng Law Firm. From December 2014 to October 2020, he served as an independent director of Eastpower Group Co., Ltd. From May 2019 to November 2025, he served as an independent director of Guangdong Sitong Group Co., Ltd. Since August 2017, he has served as an independent director of Guangdong Yida Medical Technology Co., Ltd. Since July 21, 2023, he has served as an independent director of the Company. Since December 2023, he has served as an independent director of Dongguan Hanwei Technology Co., Ltd.
During the reporting period, my position meets the independence requirements stipulated in Article 6 of the "Management Measures for Independent Directors of Listed Companies," and there are no circumstances that affect independence.
II. Performance in Attending Board Meetings, Shareholder Meetings, and Independent Director Special Committee Meetings
- In 2025, during my tenure as an independent director of the sixth board, the Company held 8 board meetings and 5 shareholder meetings. I attended all 8 board meetings and all 5 shareholder meetings. The attendance situation is as follows:
| Item | Number of Board Meetings Attended | Number of On-site Attendance | Number of Attendance via Communication | Number of Entrusted Attendance | Number of Absences | Whether Personally Attended Consecutive Meetings | Number of Shareholder Meetings Attended |
|---|---|---|---|---|---|---|---|
| This Reporting Period | 8 | 4 | 4 | 0 | 0 | No | 5 |
During the Company's board meetings, I expressed agreement on all matters reviewed by the board.
- The Company's board of directors has established four special committees: the Audit Committee, the Remuneration and Nomination Committee, the Nomination Committee, and the Strategy Committee. As the Chairman of the Remuneration and Nomination Committee and a member of the Strategy Committee of the sixth board, I have conscientiously performed my duties in accordance with the requirements of the respective committee's rules of procedure. The attendance at board special committees in 2025 is as follows:
| Committee | Audit Committee | Remuneration and Nomination Committee | Nomination Committee | Strategy Committee |
|---|---|---|---|---|
| Attended in Person | Entrusted Attendance | Attended in Person | Entrusted Attendance | |
| Number of Times | 0 | 0 | 3 | 0 |